“New Alzheimer’s drug Donanemab from Eli Lilly shows promising results in clinical trials”

2023-05-20 06:00:00

A breakthrough in Alzheimer’s therapy is said to be the new drug “Donanemab” from the US pharmaceutical company Eli Lilly. The results of the phase III study are loud Manufacturer’s press release promising and the drug effective. Therapy with the Alzheimer’s antibody has therefore slowed down the clinical deterioration of the disease by 35 percent. The patients were also 40 percent less impaired in carrying out activities of daily living.